Michael T. Massengill

873 total citations
19 papers, 659 citations indexed

About

Michael T. Massengill is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael T. Massengill has authored 19 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Ophthalmology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael T. Massengill's work include Retinal Development and Disorders (8 papers), Retinal Diseases and Treatments (6 papers) and Photoreceptor and optogenetics research (5 papers). Michael T. Massengill is often cited by papers focused on Retinal Development and Disorders (8 papers), Retinal Diseases and Treatments (6 papers) and Photoreceptor and optogenetics research (5 papers). Michael T. Massengill collaborates with scholars based in United States, China and United Kingdom. Michael T. Massengill's co-authors include Alfred S. Lewin, Cristhian J. Ildefonso, Scott Antonia, Amer A. Beg, Eric B. Haura, Weipeng Zhao, Chulbul M. Ahmed, David Noyes, Cihui Yan and Brian Ruffell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Michael T. Massengill

16 papers receiving 654 citations

Peers

Countries citing papers authored by Michael T. Massengill

Since Specialization

Citations

This map shows the geographic impact of Michael T. Massengill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Massengill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Massengill more than expected).

Fields of papers citing papers by Michael T. Massengill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Massengill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Massengill. The network helps show where Michael T. Massengill may publish in the future.

Co-authorship network of co-authors of Michael T. Massengill

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Massengill. A scholar is included among the top collaborators of Michael T. Massengill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Massengill. Michael T. Massengill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Modulation of retinal inflammation delays degeneration in a mouse model of geographic atrophy 2025 ·Scientific Reports ·(unknown), (unknown), Ji‐Eun Lee, (unknown), Michael T. Massengill, Alfred S. Lewin, Cristhian J. Ildefonso	0
2	Diagnosis of Secondary Vitreoretinal Lymphoma With Neurosurgical Stereotactic Biopsy: A Multimodal Diagnostic and Imaging Approach 2025 ·Journal of VitreoRetinal Diseases ·(unknown), (unknown), (unknown), Michael T. Massengill, William F. Mieler	0
3	Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography 2024 ·SHILAP Revista de lepidopterología ·Michael T. Massengill, (unknown), (unknown), Abhishek Sethi, Jennifer I. Lim	8
4	Occult retinopathy following treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret) 2023 ·Documenta Ophthalmologica ·Michael T. Massengill, Jason C. Park, J. Jason McAnany, (unknown)	2
5	Binocular benefit following monocular subretinal AAV injection in a mouse model of autosomal dominant retinitis pigmentosa (adRP) 2023 ·Vision Research ·Chulbul M. Ahmed, Michael T. Massengill, Cristhian J. Ildefonso, (unknown), Ping Zhu, Hong Li, (unknown), Maureen A. McCall, Alfred S. Lewin	4
6	Gene Therapy for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa 2021 ·International Ophthalmology Clinics ·Michael T. Massengill, Alfred S. Lewin	9
7	Automated segmentation and analysis of retinal microglia within ImageJ 2020 ·Experimental Eye Research ·(unknown), Michael T. Massengill, (unknown), (unknown), Alfred S. Lewin	6
8	Sectoral activation of glia in an inducible mouse model of autosomal dominant retinitis pigmentosa 2020 ·Scientific Reports ·Michael T. Massengill, (unknown), (unknown), Cristhian J. Ildefonso, Alfred S. Lewin	12
9	Corneal Opacification and Spontaneous Recovery following Injection of Healon5 into the Corneal Stroma during Intervention for Postoperative Hypotony 2020 ·Case Reports in Ophthalmology ·Michael T. Massengill, (unknown)	0
10	Expression of a CARD Slows the Retinal Degeneration of a Geographic Atrophy Mouse Model 2019 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), Michael T. Massengill, (unknown), Hong Li, Alfred S. Lewin, Cristhian J. Ildefonso	8
11	Co-Delivery of a Short-Hairpin RNA and a shRNA-Resistant Replacement Gene with Adeno-Associated Virus: An Allele-Independent Strategy for Autosomal-Dominant Retinal Disorders 2019 ·Methods in molecular biology ·Michael T. Massengill, (unknown), Alfred S. Lewin, Cristhian J. Ildefonso	8
12	A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis 2018 ·Experimental Eye Research ·Chulbul M. Ahmed, Michael T. Massengill, Emily E. Brown, Cristhian J. Ildefonso, Howard M. Johnson, Alfred S. Lewin	30
13	Neuroinflammation in Retinitis Pigmentosa, Diabetic Retinopathy, and Age-Related Macular Degeneration: A Minireview 2018 ·Advances in experimental medicine and biology ·Michael T. Massengill, Chulbul M. Ahmed, Alfred S. Lewin, Cristhian J. Ildefonso	39
14	Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector 2018 ·Proceedings of the National Academy of Sciences ·Artur V. Cideciyan, Raghavi Sudharsan, Valérie Dufour, Michael T. Massengill, Simone Iwabe, Małgorzata Świder, (unknown), Alexander Sumaroka, (unknown), (unknown), Brian Rossmiller, William W. Hauswirth, Samuel G. Jacobson, Alfred S. Lewin, Gustavo D. Aguirre, William A. Beltran	113
15	Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis Pigmentosa 2018 ·Investigative Ophthalmology & Visual Science ·Michael T. Massengill, (unknown), (unknown), (unknown), (unknown), (unknown), Hong Li, Cristhian J. Ildefonso, Alfred S. Lewin	13
16	HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma 2016 ·Clinical Cancer Research ·Hong Zheng, Weipeng Zhao, Cihui Yan, (unknown), Michael T. Massengill, Mengyu Xie, (unknown), David Noyes, Gary V. Martinez, Roha Afzal, Zhihua Chen, Xiubao Ren, Scott Antonia, Eric B. Haura, Brian Ruffell, Amer A. Beg	264
17	Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase 2016 ·Cardiovascular Research ·Michael T. Massengill, (unknown), (unknown), Stephen M. Chrzanowski, (unknown), Sonisha Warren, Glenn A. Walter, Huadong Zeng, Byung‐Ho Kang, Robert H. Anderson, Richard L. Moss, Hideko Kasahara	25
18	Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide 2016 ·Investigative Ophthalmology & Visual Science ·Cristhian J. Ildefonso, (unknown), Emily E. Brown, Ryo Iwata, Chulbul M. Ahmed, Michael T. Massengill, Manas R. Biswal, Sanford L. Boye, William W. Hauswirth, John D. Ash, Qiuhong Li, Alfred S. Lewin	30
19	Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance 2013 ·Journal of Clinical Investigation ·Emily Hopewell, Weipeng Zhao, William J. Fulp, (unknown), Alexis S. Lopez, Michael T. Massengill, Scott Antonia, Esteban Celis, Eric B. Haura, Steven A. Enkemann, (unknown), Amer A. Beg	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact